The chronic kidney disease (CKD) research program at CSU has published a number of articles featuring the work done in feline CKD. Please browse the provided abstracts for breaking research on feline CKD.

1. Summers S, Quimby JM, Isaiah A, Suchodolski JS, Lunghofer PJ, Gustafson DL. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney diseases. Accepted for publication in J Vet Intern Med, 10/30/18. 
   
2. McLeland S, Quimby J, Lappin MR. Alpha-enolase staining patters in the renal tissues of cats with and without chronic kidney disease. Publication in review, 2018. 
   
3. Summers S, McLeland S, Quimby J, Dow S, Hawley J, Coy J, Lappin MR. Serum cytokines and renal alpha-enolse immunohistochemical staining in cats after repeated administration of a parenteral FVRCP vaccine. Abstract at ACVIM conference, 2017. 
   
4. Quimby JM. Feline chronic kidney disease: understanding pathophysiology is the key to development of new treatments. Vet J 2015;203(3):265-266. DOI: 10.1016/j.tvjl.2014.12.019. 
   
5. McLeland SM, Cianciolo R, Duncan C, Quimby JM. A comparison of biochemical and histopathologic staging in cats with chronic kidney disease. Vet Path 2015:52(2):524-534. 
   
6. Quimby JM, Brock WT, Moses K, Bolotin D, Patricelli K. Maropitant for the management of vomiting and inappetence associated with chronic kidney disease in cats. J Fel Med Surg 2015:17(8):692-697. 
   
7. McLeland SM, Lunn KF, Duncan CG, Refsal KR, Quimby JM. Relationship between serum creatinine, serum gastrin, calcium-phosphorus product and uremic gastropathy in cats with chronic kidney disease. J Vet Int Med 2014;28(3):827-837.
   
8. Quimby JM, Lunn KF. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial. Vet J 2013;197(3):651-655.
   
9. Quimby JM, Maranon DG, Battaglia CLR, McLeland SM, Brock WT, Bailey SM. Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. Am J Physiol Renal Physiol 2013;305(3): F295-303.
   
10. Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pi​lot studies. Stem Cell Res Ther 2013;4(2):48.
    
11. McLeland SM, Imhoff DJ, Thomas M, Powers BE, Quimby JM. Subcutaneous fluid port-associated soft tissue sarcoma in a cat. J Fel Med Surg 2013;15(10):917-920.
    
12. Habenicht LM, Webb TL, Clauss LA, Dow SW, Quimby JM. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. J Fel Med Surg 2013;15(2):99-104.
    
13. Quimby JM, Gustafson DL, Lunn KF. The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats. J Vet Int Med 2011;25(5):985-989.
    
14. Quimby JM, Webb TL, Gibbons D, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Fel Med Surg 2011;13(6):418-26.
    
15. Whittemore JC, Hawley JR, Jensen WA, Lappin MR. Antibodies against Crandell Rees feline kidney (CRFK) cell line antigens, alpha-enolase, and annexin A2 in vaccinated and CRFK hyperinoculated cats. J Vet Intern Med 2010;24(2):306-313. 
    
16. Lappin MR, Basaraba RJ, Jensen WA. Interstitial nephritis in cats inoculated with Crandell Rees feline kidney cell lysates. J Feline Med Surg. 2006;8(5):353-356. 
    
17. Lappin MR, Jensen WA, Jensen TD, Basaraba RJ, Brown CA, Radecki SV, Hawley JR. Investigation of the induction of antibodies against Crandell-Rees feline kidney cell lysates and feline renal cell lysates after parenteral administration of vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia in cats. Am J Vet Res. 2005;66(3):506-11.